| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/CLPT.1994.62 |
| P698 | PubMed publication ID | 8181193 |
| P2093 | author name string | G R Wilkinson | |
| J Porter | |||
| R A Branch | |||
| D G May | |||
| P433 | issue | 5 | |
| P921 | main subject | dapsone | Q422226 |
| P304 | page(s) | 492-500 | |
| P577 | publication date | 1994-05-01 | |
| P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
| P1476 | title | Frequency distribution of dapsone N-hydroxylase, a putative probe for P4503A4 activity, in a white population | |
| P478 | volume | 55 |
| Q42284131 | A convenient five-drug cocktail for the assessment of major drug metabolizing enzymes: a pilot study |
| Q33866756 | A urine metabolic ratio of dextromethorphan and 3-methoxymorphinan as a probe for CYP3A activity and prediction of cyclosporine clearance in healthy volunteers. |
| Q33851108 | Aminoindoles, a novel scaffold with potent activity against Plasmodium falciparum |
| Q37278622 | Application of pharmacogenomics to malaria: a holistic approach for successful chemotherapy |
| Q40648534 | Assessment of liver metabolic function. Clinical implications |
| Q29308187 | Association of CYP2B6, CYP3A5, and CYP2C19 Genetic Polymorphisms With Sibutramine Pharmacokinetics in Healthy Korean Subjects |
| Q51370600 | Can oral midazolam predict oral cyclosporine disposition? |
| Q41619585 | Clinical pharmacokinetic considerations in the elderly. An update |
| Q70866994 | Comparison of the dapsone recovery ratio and the erythromycin breath test as in vivo probes of CYP3A activity in patients with rheumatoid arthritis receiving cyclosporine |
| Q33630473 | Cytochrome P450 enzymes and drug metabolism--basic concepts and methods of assessment |
| Q40665924 | Dapsone hypersensitivity syndrome |
| Q34417556 | Developmental therapeutics in childhood cancer. A perspective from the Children's Oncology Group and the US Food and Drug Administration |
| Q71691491 | Differences between white subjects and Chinese subjects in the in vivo inhibition of cytochrome P450s 2C19, 2D6, and 3A by omeprazole |
| Q77831628 | Differences in the urinary excretion of 6-beta-hydroxycortisol/cortisol between Asian and Caucasian women |
| Q73511095 | Effects of CYP3A inhibition on the metabolism of cilostazol |
| Q39966340 | Environmental procarcinogen hypothesis of bladder cancer in humans: Dapsone hydroxylation as a susceptibility risk factor for aggressive bladder cancer |
| Q40923059 | Gender effects in pharmacokinetics and pharmacodynamics |
| Q38165145 | Hormonal regulation of hepatic drug biotransformation and transport systems |
| Q34660699 | How important are gender differences in pharmacokinetics? |
| Q41143946 | Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacology. |
| Q41371077 | Noninvasive methods for drug measurement in pediatrics |
| Q37439873 | Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients |
| Q36964648 | Pharmacokinetic considerations in clinical toxicology: clinical applications |
| Q34296740 | Pharmacokinetic interactions of antimalarial agents |
| Q35114401 | Pharmacokinetics of dapsone in human immunodeficiency virus-infected children |
| Q36729942 | Predicted metabolic drug clearance with increasing adult age. |
| Q43554159 | Race but not age affects erythromycin breath test results in older hypertensive men. |
| Q38534443 | Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients |
| Q35049301 | The influence of sex on pharmacokinetics |
| Q73846452 | Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes |
Search more.